Nivolumab-induced hypothyoidism with consequent hypothyroid related myopathy.

Eric D JohnsonKatie KerriganKaterina ButlerShiven B Patel

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)

This case highlights the importance of early recognition and the appropriate management of endocrine immune-related adverse events to maximize patient safety and good outcomes.

Keyphrases

patient safety
quality improvement
drug induced
high glucose
late onset
metabolic syndrome
adipose tissue
glycemic control
stress induced